UK antifungal switch
This article was originally published in The Tan Sheet
Executive Summary
Galderma's Rx anti-fungal nail treatment Loceryl Nail Lacquer (amorolfine hydrochloride) is suitable for sale in the UK without a prescription because its topical application results in "very low" systemic absorption of the active ingredient, the firm says in a consultation document issued by the Medicines and Healthcare products Regulatory Agency July 18. The firm hopes to switch the Prescription Only Medication (POM) to Pharmacy (P) status under the name Curanail Lacquer. The product is applied to the nail once weekly and has been "widely used for many years and has a good safety profile," the company states. The comment deadline is Aug. 30...
You may also be interested in...
Pfizer/BioNTech’s COVID-19 Vaccine First To Be Approved In Australia
Australia will begin its coronavirus vaccination program with Comirnaty. The Oxford University/AstraZeneca vaccine is expected to be the next to receive approval.
EDQM Sets 2023 Target For Modernizing ‘Certificates Of Suitability’
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
First-Line Bavencio Bladder Cancer OK Boosts Merck KGaA
Pfizer-partnered Bavencio has struggled to compete with other checkpoint inhibitors like Keytruda, Opdivo, Imfinzi and Tecentriq, but could carve out a lucrative niche in first-line urothelial carcinoma.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: